Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H29N3O |
Molar mass | 387.527 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
CUMYL-NBMINACA (SGT-152, Cumyl-BCHpMINACA) is a synthetic cannabinoid compound first reported in a 2013 patent, but not identified as a designer drug until 2021, being identified by a forensic laboratory in Germany in February 2021.
See also
References
- WO 2014167530, Bowden MJ, Williamson PB, "Cannabinoid compounds", issued 11 April 2013
- Pulver B, Riedel J, Schönberger T, Pütz M, Schäper J, Kunert N, et al. (December 2021). "Comprehensive structural characterisation of the newly emerged synthetic cannabimimetics Cumyl-BC HpMeGaClone, Cumyl-BC HpMINACA, and Cumyl-BC HpMICA featuring a norbornyl methyl side chain". Forensic Chemistry. 26: 100371. doi:10.1016/j.forc.2021.100371. S2CID 243179410.
- "New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System" (PDF). June 2022.
This cannabinoid related article is a stub. You can help Misplaced Pages by expanding it. |